Key Points
- Director sale: Laura Oliphant sold 4,546 shares on Jan. 22 at $31.40 for $142,744.40, cutting her stake by 19.78% to 18,432 shares (valued ~ $578,764.80).
- Quarterly results: AEHR reported EPS of -$0.04 (beating the -$0.08 estimate) but revenue of $9.88M missed the $11.45M expectation and the company remains unprofitable with negative net margin and ROE.
- Market view: The stock opened at $26.78 (down ~4.5%), market cap ~$820M, 52-week range $6.27–$34.35, and carries a consensus rating of "Hold" with an average target of $21.00.
Aehr Test Systems (NASDAQ:AEHR - Get Free Report) Director Laura Oliphant sold 4,546 shares of the stock in a transaction on Thursday, January 22nd. The stock was sold at an average price of $31.40, for a total value of $142,744.40. Following the completion of the sale, the director owned 18,432 shares in the company, valued at $578,764.80. This trade represents a 19.78% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Aehr Test Systems Stock Down 4.5%
Aehr Test Systems stock opened at $26.78 on Tuesday. The stock has a market cap of $820.27 million, a price-to-earnings ratio of -89.26 and a beta of 2.33. The business has a 50-day simple moving average of $23.76 and a 200 day simple moving average of $23.75. Aehr Test Systems has a 52 week low of $6.27 and a 52 week high of $34.35.
Aehr Test Systems (NASDAQ:AEHR - Get Free Report) last released its quarterly earnings results on Thursday, January 8th. The semiconductor company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.04. Aehr Test Systems had a negative return on equity of 4.57% and a negative net margin of 16.63%.The firm had revenue of $9.88 million for the quarter, compared to analysts' expectations of $11.45 million. On average, research analysts anticipate that Aehr Test Systems will post 0.1 earnings per share for the current year.
Analyst Upgrades and Downgrades
A number of brokerages have recently commented on AEHR. Craig Hallum reissued a "hold" rating on shares of Aehr Test Systems in a report on Friday, January 9th. Weiss Ratings reiterated a "sell (d)" rating on shares of Aehr Test Systems in a research report on Wednesday, January 21st. Lake Street Capital initiated coverage on Aehr Test Systems in a research report on Wednesday, December 17th. They set a "buy" rating on the stock. Finally, Zacks Research raised Aehr Test Systems from a "strong sell" rating to a "hold" rating in a research note on Monday, December 8th. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $21.00.
Check Out Our Latest Report on AEHR
Hedge Funds Weigh In On Aehr Test Systems
Several institutional investors and hedge funds have recently made changes to their positions in the business. Royal Bank of Canada lifted its stake in Aehr Test Systems by 262.7% in the first quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company's stock worth $365,000 after purchasing an additional 36,364 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Aehr Test Systems by 8.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company's stock worth $126,000 after buying an additional 1,344 shares during the period. CWM LLC lifted its stake in shares of Aehr Test Systems by 15.1% in the 2nd quarter. CWM LLC now owns 6,062 shares of the semiconductor company's stock valued at $78,000 after acquiring an additional 793 shares during the last quarter. Penbrook Management LLC boosted its holdings in Aehr Test Systems by 205.1% during the 2nd quarter. Penbrook Management LLC now owns 126,250 shares of the semiconductor company's stock valued at $1,632,000 after acquiring an additional 84,875 shares during the period. Finally, AlphaQuest LLC grew its position in Aehr Test Systems by 697.6% during the 2nd quarter. AlphaQuest LLC now owns 20,156 shares of the semiconductor company's stock worth $261,000 after acquiring an additional 17,629 shares during the last quarter. Institutional investors own 69.69% of the company's stock.
About Aehr Test Systems
(
Get Free Report)
Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.
The company's product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
